Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years
Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Top Performing Pharma and Healthcare Mutual Funds in Last 3 Years

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

DSIJ Intelligence-2 Article rating: 5.0

Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.

Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes
Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes

Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes

The total inflows standing at Rs 40,063 crore in February compared to Rs 1,87,550 crore in January, according to data from the Association of Mutual Funds of India (AMFI) released on March 12.

DSIJ Intelligence-2 Article rating: 5.0
IndusInd Bank Shares Crash 26 Per cent Due to Rs 1,580 Crore Forex Derivative Loss; Here are Top 5 Mutual Funds Holding the Stock
IndusInd Bank Shares Crash 26 Per cent Due to Rs 1,580 Crore Forex Derivative Loss; Here are Top 5 Mutual Funds Holding the Stock

IndusInd Bank Shares Crash 26 Per cent Due to Rs 1,580 Crore Forex Derivative Loss; Here are Top 5 Mutual Funds Holding the Stock

IndusInd Bank shares fell 26 per cent due to forex derivative misaccounting, resulting in a Rs 1,580 crore loss. Analysts downgraded the stock, citing governance concerns and earnings pressure.

DSIJ Intelligence-2 Article rating: 3.6
RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList